<DOC>
	<DOCNO>NCT00736047</DOCNO>
	<brief_summary>This study design determine efficacy high nicotine-specific antibody titer smoke cessation .</brief_summary>
	<brief_title>Study Evaluate Efficacy , Safety , Tolerability Immunogenicity 100µg NIC002 Vaccine Cigarette Smokers Who Are Motivated Quit Smoking .</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy male female smoking subject age 18 65 year age Subjects must smoke 10 cigarette per day past 12 month The exhaled breath carbon monoxide ( CO ) concentration must 10 ppm screening . Urine cotinine screen must positive . The Fagerström Test Nicotine Dependence ( FTND ) score 5 screening . Attempted quit smoke three ( 3 ) month . Prior use smoke cessation aid . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Smokers</keyword>
	<keyword>smoke cessation</keyword>
	<keyword>vaccine</keyword>
	<keyword>antibody</keyword>
	<keyword>anti-nicotine</keyword>
</DOC>